AlphAIalphai — Financial news for AI agents
rttnews.comAUG 272 min read$HQY

HealthEquity Stock Falls 14% Despite Higher Q2 Profit

HealthEquity (HQY) shares dropped 14% to $89.85 despite reporting higher Q2 profit. Net income rose to $65.644M ($0.78 per share) from $59.854M ($0.68 per share) year-over-year. Revenue increased 7.6% to $350.732M. Trading volume was 612,215 shares.

Original reporting
rttnews.com
Published Aug 27, 2026, 3:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 4:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$HQY
Bearish
high confidence
Mentioned
$HQY
Relevance
8/10
alphai data visualization · based on rttnews.com
Decision brief

The 30-second read

$HQYBearishHigh
01

Why it matters

The earnings miss triggered a near‑15% sell‑off, suggesting short‑term weakness.

02

Market read

Earnings-driven price action offers a trading opportunity on the downside.

03

What to watch

Potential upside from upcoming payer contracts not reflected in the release.

Relevance 8/10Novelty 9/10Timing: post-market Thursday

Background

HealthEquity provides health‑savings account platforms; Q2 results were released after market close.

Company-level read

Ticker impact

$HQYBearishHigh confidence
Context

Q2 earnings beat profit expectations but revenue miss led to a 14% share decline.

Expected impact

Potential further decline if guidance remains weak.

Evidence & confidence

Profit rose YoY but revenue growth slowed; market reacted negatively.

Market effects

Sector

HealthEquity's miss may pressure other health‑tech stocks.

Regional

U.S. market sentiment dampened in the healthcare services sector.

Global

Limited to U.S. equities; no broader macro effect.

Counterpoint

What could challenge this read

Despite revenue slowdown, profit growth could support a bounce if guidance improves.

Key entities

  • company
    HealthEquity, Inc.

    Provider of consumer‑direct health‑savings accounts.

Read at source← All news

Related articles

AUG 27
$HQYHighAI 8/10

HealthEquity, Inc. Q2 2027 Earnings Call Summary

HealthEquity, Inc. reported Q2 2027 record adjusted EBITDA margins of 48% and 24% new HSA sales growth. The company raised fiscal 2027 revenue guidance to $1.411B–$1.421B and plans to roll out a next-gen app. Invested HSA assets increased 28% YoY. Management highlighted AI-driven cost reductions and Marketplace growth.

yahoo.com2 min
AUG 27
$HQYMed

Why is HealthEquity stock sliding today?

HealthEquity (HQY) stock fell 7.6% pre-market after Q2 FY2027 results met expectations but lacked upside. Revenue rose 8% to $350.7M, EPS increased 15% to $1.24. CEO highlighted record metrics, and guidance was raised. The decline is attributed to modest earnings growth and high market expectations.

investing.com2 min
AUG 27
$HQYHigh

HEALTHEQUITY, INC. (HQY): Results of Operations and Financial Condition

HEALTHEQUITY, INC. (HQY) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results Highlights of the second quarter include: • Net income increased 10% to $65.6 million , and net income margin increased to 19% from 18% last year. • Adjusted EBITDA increased 11% to $167.0 million , and Adj

SEC EDGAR 8-K2 min
JUL 30
$HQYMed

HealthEquity rating upgraded by Moody’s on strong cash flow

Moody’s upgraded HealthEquity, Inc. (NASDAQ:HQY) corporate family rating to Ba2 from Ba3 and raised its probability of default rating to Ba2-PD from Ba3-PD. It also upgraded $600 million senior unsecured notes to Ba3 from B1, with outlook changed to stable. Moody’s cited stronger operating cash flow and BenefitWallet integration, plus improved leverage and liquidity.

investing.com3 min
MAY 28
$HQYMedAI 9/10

HealthEquity Q1 2027 Earnings Call: Complete Transcript - HealthEquity (NASDAQ: HQY)

HealthEquity reported fiscal 2027 first-quarter results, citing 7% year-over-year revenue growth and a record adjusted EBITDA margin of 46%, according to the company. It raised guidance to $1.41–$1.42B revenue and $625–$633M adjusted EBITDA. The firm said it expanded digital engagement and Marketplace, used AI for efficiency, saw HSA assets +19% and new HSA sales +15%, and increased its share repurchase authorization by $1B.

benzinga.com6 min